FDA Clears Next-Generation AI Software for Portable Brain MRI
The Optive AI software, the tenth software release for the Swoop portable MRI system, reportedly offers enhanced clarity and anatomical detail for ultra-low-field MRI of the brain.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Optive AI software, which may significantly elevate the quality of ultra-low-field brain MRI scans.
The tenth software release for the Swoop portable MRI system, the Optive AI software utilizes advanced algorithms to bolster noise cancellation, image reconstruction and post-processing, according to Hyperfine, the developer of the Swoop MRI platform.
The newly FDA-cleared Optive AI software (see MRI scan on the right) enhances the clarity and anatomical details of ultra-low-field MRI scans obtained with the Swoop portable MRI system, according to Hyperfine, the manufacturer of the Swoop system. (Images courtesy of Hyperfine.)
Hyperfine noted that use of the Optive AI software allows for sharper clarity and anatomical detail across all sequences obtained with ultra-low-field brain MRI.
“The advanced AI algorithms integrated into our new software platform dramatically elevate image quality at ultra-low field strength, enabling more confident diagnoses at the point of care,” noted Rafael O’Halloran, the vice president of technology at Hyperfine.
The company said the Optive AI software will be available in the third quarter of 2025.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
